Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-4-9
pubmed:abstractText
Cystic fibrosis patients have chronic bacterial infections of the respiratory tract, most commonly Pseudomonas aeruginosa. Although controversial, administration of antibiotic therapy during acute pulmonary exacerbations is standard practice. Fluoroquinolones are currently not indicated for use in young children because of the observation of arthropathy and damage to growing cartilage in beagle puppies. Because of its activity against P. aeruginosa and excellent oral bioavailability, ciprofloxacin offers a unique therapeutic alternative for this patient population.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0891-3668
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
97-105; discussion 123-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9002118-Acute Disease, pubmed-meshheading:9002118-Adolescent, pubmed-meshheading:9002118-Anti-Infective Agents, pubmed-meshheading:9002118-Arthralgia, pubmed-meshheading:9002118-Ceftazidime, pubmed-meshheading:9002118-Child, pubmed-meshheading:9002118-Child, Preschool, pubmed-meshheading:9002118-Ciprofloxacin, pubmed-meshheading:9002118-Cystic Fibrosis, pubmed-meshheading:9002118-Double-Blind Method, pubmed-meshheading:9002118-Drug Therapy, Combination, pubmed-meshheading:9002118-Female, pubmed-meshheading:9002118-Humans, pubmed-meshheading:9002118-Logistic Models, pubmed-meshheading:9002118-Male, pubmed-meshheading:9002118-Pneumonia, Bacterial, pubmed-meshheading:9002118-Prospective Studies, pubmed-meshheading:9002118-Pseudomonas Infections, pubmed-meshheading:9002118-Tobramycin, pubmed-meshheading:9002118-Treatment Outcome
pubmed:year
1997
pubmed:articleTitle
Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
pubmed:affiliation
University of Kentucky Medical Center, Lexington, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't